CME Group (CME) to Release Earnings on Wednesday

CME Group (NASDAQ:CME) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.69 per share and revenue of $1.6351 billion for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:30 AM ET.

CME Group Trading Up 0.2%

Shares of CME opened at $284.48 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $102.58 billion, a PE ratio of 27.57, a PEG ratio of 3.20 and a beta of 0.27. CME Group has a 1 year low of $232.32 and a 1 year high of $290.79. The stock has a 50 day simple moving average of $274.37 and a 200-day simple moving average of $272.05.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Viking Global Investors LP acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $164,648,000. Invesco Ltd. grew its holdings in CME Group by 23.0% during the 3rd quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock worth $764,725,000 after acquiring an additional 528,358 shares during the period. Caisse de depot et placement du Quebec grew its holdings in CME Group by 6,579.0% during the 3rd quarter. Caisse de depot et placement du Quebec now owns 307,768 shares of the financial services provider’s stock worth $83,156,000 after acquiring an additional 303,160 shares during the period. Credit Agricole S A bought a new stake in shares of CME Group during the 3rd quarter valued at $68,925,000. Finally, Alyeska Investment Group L.P. acquired a new position in shares of CME Group in the 3rd quarter valued at $63,880,000. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group lowered their target price on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. The Goldman Sachs Group decreased their price objective on shares of CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a research note on Wednesday, January 14th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Raymond James Financial boosted their target price on CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a report on Monday, January 5th. Finally, Keefe, Bruyette & Woods raised their price target on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $292.18.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.